Silver prices have shattered records, with spot silver leaping 4% to $74.82 per ounce on December 26, after touching an all-time high of $75.14 earlier in the session, capping a remarkable 158% year-to-date rally that has transformed the precious metal […]
AMD stock has sparked renewed investor interest in late December 2025, climbing 3.2% to close at $162.50 on December 26 following reports that the incoming Trump administration is poised to negotiate a deal allowing AMD to resume sales of its
Nvidia, the dominant force in artificial intelligence hardware, has sealed a landmark agreement to acquire key assets from Groq Inc., the nine-year-old AI chip startup, in a transaction valued at approximately $20 billion Nvidia’s biggest deal on record and one
Microsoft stock has demonstrated resilience in late 2025, maintaining a 16% year-to-date gain to close at $425.80 on December 24, despite a swirl of scepticism surrounding its aggressive artificial intelligence investments and deepening ties with OpenAI. The latest catalyst a
Novo Nordisk A/S (NYSE: NVO) shares rocketed more than 9% in premarket trading on December 23, 2025, extending gains after the U.S. Food and Drug Administration approved an oral version of the company’s blockbuster Wegovy obesity treatment, marking the first-ever
Rocket Lab USA Inc. (NASDAQ: RKLB), the innovative aerospace firm pioneering small satellite launches, has captured investor attention with a dramatic stock surge in late December 2025, climbing nearly 10% to close at $77.55 on December 22 following the successful
Permira, the London-based private equity giant, has agreed to sell a majority stake in Golden Goose, the iconic Italian luxury sneaker brand, to HSG Group, a Hong Kong-headquartered Chinese investment firm, in a transaction valued at approximately €1.3 billion. The
Medtronic plc (NYSE: MDT), the global medical device leader, took a significant step toward unlocking value in its high-growth diabetes segment on December 19, 2025, when its MiniMed Group subsidiary confidentially filed a registration statement with the U.S. Securities and
Nike shares plummeted more than 10% in premarket trading on December 19, 2025, extending losses after the sportswear behemoth reported fiscal second-quarter 2026 results that beat revenue and earnings expectations but revealed persistent challenges in China and escalating tariff pressures.
Nike Shares Plunge 10% After Q2 Earnings Beat on China Weakness and Tariff Fears Read More »
BioMarin Pharmaceutical (BMRN) announced on December 19, 2025, that it has entered into a definitive agreement to acquire Amicus Therapeutics Inc. (NASDAQ: FOLD) in an all-cash transaction valued at approximately $4.8 billion, creating a formidable powerhouse in the rare disease
